Friday, April 08, 2005

CAFC revises Glaxo/Apotex paroxetine opinion: now inherent anticipation

On April 8, 2005, a panel of the CAFC issued a revised decision in the paroxetine case between Glaxo SKB and Apotex. Glaxo now loses for inherent anticipation. The prior decision about the experimental use exception is gone.


Post a Comment

<< Home